WF
Insider
W. Michael Flanagan
Chief Scientific OfficerW. Michael Flanagan (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $473K of RNA (6,534 sh across 2 lots, as filed), executed Jan 21.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$645K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Volume by month
Buys $0
Sells $7.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
RNA
RNA
RNA · 0 buys · 11 sells
11 filings
Recent filings
RNASALE
Avidity Biosciences, Inc.
View filing →
$858K24,000 sh × $35.77
Exec Dec 11 2024
Filed Dec 13 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $3.0M
62,500 sh × $47.62
Exec Oct 1 2024
Filed Oct 3 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $1.1M
25,000 sh across 2 lots
Exec Sep 23 2024
Filed Sep 23 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $4.5M
111,394 sh across 3 lots
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET